Neogen Corporation (NEOG) - Total Assets
Based on the latest financial reports, Neogen Corporation (NEOG) holds total assets worth $3.36 Billion USD as of February 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore NEOG debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Neogen Corporation - Total Assets Trend (1988–2025)
This chart illustrates how Neogen Corporation's total assets have evolved over time, based on quarterly financial data. See Neogen Corporation book value and equity for net asset value and shareholders' equity analysis.
Neogen Corporation - Asset Composition Analysis
Current Asset Composition (May 2025)
Neogen Corporation's total assets of $3.36 Billion consist of 16.8% current assets and 83.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.8% |
| Accounts Receivable | $153.38 Million | 4.5% |
| Inventory | $190.86 Million | 5.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.41 Billion | 41.0% |
| Goodwill | $1.06 Billion | 30.9% |
Asset Composition Trend (1988–2025)
This chart illustrates how Neogen Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Neogen Corporation market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neogen Corporation's current assets represent 16.8% of total assets in 2025, a decrease from 71.2% in 1988.
- Cash Position: Cash and equivalents constituted 3.8% of total assets in 2025, down from 21.2% in 1988.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 70.0% of total assets, an increase from 1.0% in 1988.
- Asset Diversification: The largest asset category is intangible assets at 41.0% of total assets.
Neogen Corporation Competitors by Total Assets
Key competitors of Neogen Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Neogen Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.92 | 3.91 | 11.03 |
| Quick Ratio | 2.84 | 2.45 | 9.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $439.40 Million | $410.51 Million | $537.85 Million |
Neogen Corporation - Advanced Valuation Insights
This section examines the relationship between Neogen Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.96 |
| Latest Market Cap to Assets Ratio | 0.59 |
| Asset Growth Rate (YoY) | -24.3% |
| Total Assets | $3.44 Billion |
| Market Capitalization | $2.02 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Neogen Corporation's assets below their book value (0.59x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Neogen Corporation's assets decreased by 24.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Neogen Corporation (1988–2025)
The table below shows the annual total assets of Neogen Corporation from 1988 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-05-31 | $3.44 Billion | -24.29% |
| 2024-05-31 | $4.55 Billion | -0.12% |
| 2023-05-31 | $4.55 Billion | +358.69% |
| 2022-05-31 | $992.93 Million | +7.90% |
| 2021-05-31 | $920.19 Million | +15.43% |
| 2020-05-31 | $797.18 Million | +14.58% |
| 2019-05-31 | $695.74 Million | +12.58% |
| 2018-05-31 | $618.01 Million | +16.96% |
| 2017-05-31 | $528.41 Million | +16.98% |
| 2016-05-31 | $451.71 Million | +15.18% |
| 2015-05-31 | $392.18 Million | +13.58% |
| 2014-05-31 | $345.30 Million | +19.38% |
| 2013-05-31 | $289.25 Million | +14.96% |
| 2012-05-31 | $251.60 Million | +14.54% |
| 2011-05-31 | $219.66 Million | +21.88% |
| 2010-05-31 | $180.23 Million | +26.77% |
| 2009-05-31 | $142.18 Million | +12.52% |
| 2008-05-31 | $126.36 Million | +20.02% |
| 2007-05-31 | $105.28 Million | +19.25% |
| 2006-05-31 | $88.29 Million | +38.20% |
| 2005-05-31 | $63.88 Million | +6.52% |
| 2004-05-31 | $59.98 Million | +24.85% |
| 2003-05-31 | $48.04 Million | +20.38% |
| 2002-05-31 | $39.90 Million | +20.84% |
| 2001-05-31 | $33.02 Million | +11.83% |
| 2000-05-31 | $29.53 Million | +13.13% |
| 1999-05-31 | $26.10 Million | +2.76% |
| 1998-05-31 | $25.40 Million | +9.96% |
| 1997-05-31 | $23.10 Million | +100.87% |
| 1996-05-31 | $11.50 Million | 0.00% |
| 1995-05-31 | $11.50 Million | +26.37% |
| 1994-05-31 | $9.10 Million | +24.66% |
| 1993-05-31 | $7.30 Million | -3.95% |
| 1992-05-31 | $7.60 Million | -10.59% |
| 1991-05-31 | $8.50 Million | -9.57% |
| 1990-05-31 | $9.40 Million | +104.35% |
| 1989-05-31 | $4.60 Million | -11.54% |
| 1988-05-31 | $5.20 Million | -- |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne path… Read more